Occupational Therapists in Maplewood, MN Accepting Medicare

51 Occupational Therapists found. Showing 41 - 51

Ashleymarie Patricia Hirdler, OTD, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2001 Beam Ave, Maplewood, MN 55109 Phone: 763-310-7342

Mary Martha Clark, OTR-L Occupational Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2495 Maplewood Drive, Suite 313, Maplewood, MN 55109 Phone: 651-770-8884    Fax: 651-770-8151

Adaline Boden, OTR/L Occupational Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2495 Maplewood Dr, Maplewood, MN 55109 Phone: 651-770-8884

Mrs. Janet Work Stine, OTRL Occupational Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2495 Maplewood Drive, Suite 313, Maplewood, MN 55109 Phone: 651-770-8884    Fax: 651-770-8151

Charisse Margaret Courteau, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2495 Maplewood Dr, Maplewood, MN 55109 Phone: 651-770-8884    Fax: 651-771-8151

Ms. Holly Marie Brown, COTA/L Occupational Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2495 Maplewood Dr N Ste 313, Maplewood, MN 55109 Phone: 651-770-8884

Sarah Braski Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 1856 Beam Ave, Suite 100, Maplewood, MN 55109 Phone: 763-201-8191

Karla Jean Ethier, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1670 Legacy Pkwy E, Maplewood, MN 55109 Phone: 651-777-1641

Kristi Kay Worrell, OTR-L Occupational Therapist - Pediatrics Medicare: Medicare Enrolled Practice Location: 2495 Maplewood Drive, Suite 313, Maplewood, MN 55109 Phone: 651-770-8884    Fax: 651-770-8151

Chrissy Vang, MOT, OTR/L Occupational Therapist - Pediatrics Medicare: Medicare Enrolled Practice Location: 2495 Maplewood Dr N Ste 313, Maplewood, MN 55109 Phone: 651-770-8884

Janice Kay Herold-maho, OTR-L Occupational Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2495 Maplewood Drive, Suite 313, Maplewood, MN 55109 Phone: 651-770-8884    Fax: 651-770-8151

News Archive

Study provides insight into how poor sleep quality can increase heart disease risk in women

Women who sleep poorly tend to overeat and consume a lower-quality diet, according to a new study from researchers at Columbia University Irving Medical Center.

Survey shows radiation oncologists desire for more formal guidance to improve peer review process

Peer review is a common practice in medicine to support the complementary, multidisciplinary team approach in healthcare. A 2013 survey of radiation oncologists indicates that they would like more formal recommendations and guidance in order to improve the peer review process, according to a study published in the January-February 2015 issue of Practical Radiation Oncology, the clinical practice journal of the American Society for Radiation Oncology.

Mainstream model of medical care may not be the answer for eliminating disparities in African American population

Having a health clinic in the apartment next door may not be everyone's idea of a good neighbor. But a new study shows that such a clinic can be much more effective than a traditional one in improving African American's heart health.

Cybex International re-brands its research division as Cybex Institute For Exercise Science

Cybex International, Inc., a leading manufacturer of premium exercise equipment for the commercial and consumer markets, announced today the re-branding of its research arm as the Cybex Institute for Exercise Science, with the continued mission of disseminating scientifically accurate information applicable to the disciplines of general fitness, sports performance and clinical medicine.

FDA assigns new PDUFA date for Takeda's investigational type 2 diabetes therapy, alogliptin

Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Global Research & Development Center, Inc., U.S., today announced that the company received notification from the U.S. Food and Drug Administration (FDA) that its review of investigational type 2 diabetes therapy alogliptin, and thus the fixed-dose combination therapy alogliptin/pioglitazone, will be delayed.

Read more Medical News

› Verified 1 days ago

• 1
• 2
• 3(current)